Results 1,121-1,140 of 2,965 for speaker:Robert Dowds
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: Who has benefited from the prescribing of the most expensive brands? Is it simply the pharmaceutical companies or does it go wider than that?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: Would it be in the interests of the pharmacists or the intermediaries between the companies and the pharmacists to-----
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: To what extent are there signs of better practice coming into play in terms of GPs prescribing expensive drugs?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: Is Mr. O'Brien saying the doctors are responding positively?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: That obviously is very useful. With the high costs for drugs in the past, are the pharmaceutical companies, in a sense, forcing us to pay a high price as a quid pro quo for keeping their operations here? Is there any evidence of that?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: Does that mean our negotiators have been much less effective than negotiators in countries such as Spain or the United Kingdom?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: What has been happening seems to be a scandal in that so much money is being wasted which could be much better used elsewhere. Clearly we need to have the drugs, but if we could have them at, for example, a 50% reduction it would leave the health services in a much better place financially. What percentage savings can we expect?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: It has reduced by €5.
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: Is it correct that in some cases the HSE is reimbursing pharmacists by between 40% and 90% of the actual cost of the drug? If so, why is that the case?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: By not playing in that space is the HSE not losing out on the possibility of saving money for the taxpayer?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: I ask Mr. O'Brien to explain what he means by that being an area in which the HSE cannot play. On behalf of the taxpayer, I would like the HSE to play in it, if it would reduce our bills. I did not quite get one aspect of the point Mr. O'Brien made.
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: That is what I mean.
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: Above the counter a particular jar costs €20, but in an underhand sale it would be only €14.
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: It strikes me that there is a real need for the HSE to get at this because of the obvious savings which would accrue. Mr. O'Brien seems to be suggesting the changes anticipated will help to eliminate this. Am I correct in stating this? If I am, on what basis does Mr. O'Brien believe the anticipated changes will help to deal with the issue?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: It all points to something which has been a general problem in this country and not only in the area of health. If a private operator has been screwing as much money out of the State as possible, traditionally we have been too compliant because we do not see ourselves as being the State. I hope we can make progress in this regard because it would be so much more beneficial for all of us and...
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: A total of 140 HSE properties have been lying idle for more than ten years. Costs are involved in securing these properties. Any building lying idle is a waste because it is not being used and it incurs security and maintenance costs. Are these properties owned by the HSE or does it have a long lease on them? I ask for further information on this area.
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: What types of properties are these? To what extent are they owned by the HSE?
- Public Accounts Committee: 2011 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 40 - Health Service Executive
Health Service Executive Financial Statements 2011 (25 Apr 2013) Robert Dowds: It is an important one and not only for the health service. The State is paying for too many buildings which are not being fully utilised. I ask the Chairman to return to this issue.
- Joint Oireachtas Committee on Health and Children: Organ Donation: Discussion (Resumed) (25 Apr 2013)
Robert Dowds: How do they compare to politicians?
- Leaders' Questions (30 Apr 2013)
Robert Dowds: Have him treated for amnesia.